一品红：全资子公司获左氧氟沙星口服溶液注册证书

Group 1 - The core point of the article is that Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical, has received approval from the National Medical Products Administration for the registration of Levofloxacin oral solution, which is classified as a Class 3 chemical drug and is considered to have passed the consistency evaluation [1] - The drug has a wide range of indications and can be used to treat various bacterial infections [1] - The estimated sales scale of Levofloxacin in domestic urban and county-level public hospitals is approximately 401 million yuan in 2024 [1] Group 2 - The approval allows the company to have domestic sales qualifications, which will enrich its product pipeline and enhance its competitiveness in the anti-infection field [1] - There is a potential risk that sales after the drug's launch may not meet expectations [1]